Swiss Rockets
Group of Companies

Igniting Breakthrough
Biotech Startups

ABOUT
THE GROUP

ABOUT
THE GROUP

ABOUT US

Founded in 2018, the Swiss Rockets Group is an innovative umbrella company with a portfolio of several niche-leading biotech companies ranging from late-stage pre-clinical to Phase II.

Download Company Factsheet

MISSION

To identify, invest in and cultivate the most promising biotech startups in Switzerland, Europe, and the US.

BUSINESS MODEL

Accelerating growth of biotech leaders and maximizing impact through mentorship, funding and access (to a wide spectrum of resources, legal and regulatory guidance as well as a broad network of world-class industry experts).

OUR MISSION

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the way cancer, infectious diseases and autoimmune disorders are treated – striving for a more effective, equitable, and accessible healthcare for patients around the world.

Motivating and Empowering
inventors of novel,
life-changing therapies

Striving for Excellence
in Scientific Discovery and
Clinical Innovation

Investing in Bold Ideas
and Prioritizing Patient
Well-being

Nurturing a Sustainable
Ecosystem with Scientific
and Business Acumen

Improving Global Health
Outcomes through
Breakthrough Medicines

Leading the Biotech industry
through a collaborative,
science-first approach

Overcoming Unmet Medical
Needs and Leading the
Biotech Industry

Supporting Cutting Edge
Technologies and Fostering
Collaborative Innovation

Incubator
Services

  • Collaboration with cantonal and federal governments
  • Access to world-wide scientific experts in their respective fields
  • Access to high expertise in legal, regulatory and financial affairs
  • Design and operations in preclinical and clinical development, and manufacturing
  • Expertise in corporate governance

Accelerator
Services

Accelerate

Designed to accelerate growth and achieve goals.

Provide

Provide financial resources, mentorship, drug development expertise, and guidance on business and management topics.

Support

Designed to accelerate growth and achieve goals.

Experience

Designed to accelerate growth and achieve goals.

Management
Services

  • Expertise in drug discovery, drug development, manufacturing, regulatory affairs, clinical operations, intellectual property.

  • Expertise in legal support, IT support, market access, financing, business development, and partnering with big pharma.

Swiss Rockets AG aims to be one of leading incubators and accelerators of biotech startups.

Founding Story
Established in 2018 by seasoned entrepreneurs and investors to nurture promising biotech startups.

Core Mission
Identifying, investing in, and developing the most promising biotech startups in Switzerland and Europe.

Unique Approach
Rigorous screening process to identify startups with the most promising technologies and strong teams.

Cutting-Edge Technologies
Providing access to state-of-the-art facilities and technologies to accelerate product development.

Strategic Partnerships
Leveraging a vast network to connect portfolio companies with strategic partners and investors.

Comprehensive Resources
We will continue to provide access to funding, mentorship, drug development support, legal and regulatory guidance, access to industry experts and investors and office, laboratory, and manufacturing space.

Innovative Portfolio
We aim to expand our biotech portfolio to autoimmune disorders, neurodegenerative diseases, and rare genetic disorders on top of oncology and infectious diseases.

Continued Support
With a strong network of investors and partners, Swiss Rockets AG is well positioned to continue supporting the most promising biotech startups and driving scientific innovation for improved patient outcomes.

LATEST NEWS

12 March 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

7 March 2025

Torqur AG Presents Interim Phase 2 Clinical Trial Results at American Academy of Dermatology

25 February 2025

Spotlight on Leadership: Dr. Vladimir Cmiljanovic in The CEO Magazine

More news

Download Our
Company Factsheet

your name

your email

organization name

Download Company Factsheet